NASDAQ
Aura Biosciences, Inc. (AURA) has a fcf yield of -25.91% as of Monday, August 3, 2026. This represents a 64.66% decrease compared to its 12-month average of -15.73%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.